BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/24/2023 1:35:50 PM | Browse: 308 | Download: 578
 |
Received |
|
2022-09-18 09:51 |
|
Peer-Review Started |
|
2022-09-18 09:53 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-10-31 01:18 |
|
Revised |
|
2022-11-13 05:39 |
|
Second Decision |
|
2023-01-20 03:30 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-01-23 15:26 |
|
Articles in Press |
|
2023-01-23 15:26 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-01-09 03:55 |
|
Typeset the Manuscript |
|
2023-01-28 08:19 |
|
Publish the Manuscript Online |
|
2023-02-24 13:35 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Current status and prospect of treatments for recurrent hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yu-Qing Yang, Zhen-Yu Wen, Xiao-Yan Liu, Zhen-Hu Ma, Yan-E Liu, Xue-Ying Cao, Li Hou and Hui Xie |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hui Xie, MD, Chief Doctor, Department of Interventional Therapy, 302 Hospital of People’s Liberation Army, No. 100, Western 4th Ring Middle Road, Fengtai District, Beijing 100039, China. xh302jr@126.com |
| Key Words |
Review; Recurrence; Hepatocellular carcinoma; Hepatectomy; Liver transplantation; Transcatheter arterial chemoembolization |
| Core Tip |
The current rate of recurrence after initial hepatocellular carcinoma treatment remains unsatisfactory. Repeat hepatectomy and salvage liver transplantation are the preferred options for patients who meet the criteria. However, for patients whose clinical situation do not allow these treatments, non-surgical treatment can also provide survival benefits. Additionally, adjuvant treatment strategies to prevent recurrence and proper surveillance are effective tools to improve overall patient survival. This review summarizes the existing literature to help guide clinical decision-making and provide directions for further research. |
| Publish Date |
2023-02-24 13:35 |
| Citation |
Yang YQ, Wen ZY, Liu XY, Ma ZH, Liu YE, Cao XY, Hou L, Hui X. Current status and prospect of treatments for recurrent hepatocellular carcinoma. World J Hepatol 2023; 15(2): 129-150 |
| URL |
https://www.wjgnet.com/1948-5182/full/v15/i2/129.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v15.i2.129 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
